What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Chemotherapy
His main research concerns Internal medicine, Surgery, Transplantation, Leukemia and Hematopoietic stem cell transplantation.
His work deals with themes such as Gastroenterology and Oncology, which intersect with Internal medicine.
Frederick R. Appelbaum regularly links together related areas like Disease in his Surgery studies.
The various areas that Frederick R. Appelbaum examines in his Transplantation study include Immunology, Bone marrow, Transplantation Conditioning and Cyclophosphamide.
His Leukemia study often links to related topics such as Myeloid.
His Hematopoietic stem cell transplantation study incorporates themes from Immunosuppression, Minimal residual disease, Hazard ratio, Severity of illness and Comorbidity.
His most cited work include:
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. (2438 citations)
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel (2002 citations)
- Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study (1447 citations)
What are the main themes of his work throughout his whole career to date?
Frederick R. Appelbaum mainly focuses on Internal medicine, Transplantation, Oncology, Surgery and Myeloid leukemia.
The study incorporates disciplines such as Gastroenterology and Immunology in addition to Internal medicine.
His Transplantation research includes elements of Hematopoietic cell, Total body irradiation and Bone marrow.
His work in Oncology addresses subjects such as Cytarabine, which are connected to disciplines such as Daunorubicin.
Frederick R. Appelbaum interconnects Cancer, Disease and Complete remission in the investigation of issues within Myeloid leukemia.
His Leukemia research includes themes of Myeloid and Pediatrics.
He most often published in these fields:
- Internal medicine (96.75%)
- Transplantation (60.48%)
- Oncology (47.59%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (96.75%)
- Oncology (47.59%)
- Transplantation (60.48%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Oncology, Transplantation, Myeloid leukemia and Leukemia.
His work in Hematopoietic stem cell transplantation, Cytarabine, Chemotherapy regimen, Chemotherapy and Myeloid are all subfields of Internal medicine research.
His Oncology research integrates issues from Clinical trial, Disease, NPM1, Survival analysis and Acute leukemia.
His work carried out in the field of Transplantation brings together such families of science as Hematopoietic cell, Regimen, Complete remission and Intensive care medicine.
His Myeloid leukemia research is multidisciplinary, incorporating perspectives in Gastroenterology, Newly diagnosed and Bone marrow.
Frederick R. Appelbaum usually deals with Minimal residual disease and limits it to topics linked to Surgery and Transplantation Conditioning.
Between 2015 and 2021, his most popular works were:
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel (2002 citations)
- Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation (802 citations)
- Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease–Based Definition of Complete Remission? (223 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Chemotherapy
His scientific interests lie mostly in Internal medicine, Oncology, Transplantation, Myeloid leukemia and Leukemia.
Frederick R. Appelbaum has researched Internal medicine in several fields, including Gastroenterology and Surgery.
His study looks at the intersection of Surgery and topics like Transplantation Conditioning with Bone marrow examination and Survival rate.
His study in Oncology is interdisciplinary in nature, drawing from both Proportional hazards model, Cytotoxic T cell, Survival analysis, Cohort and Comorbidity.
His Transplantation research is multidisciplinary, incorporating elements of Hematopoietic cell, Complete remission and Treatment Arm.
His Leukemia research incorporates elements of Chemotherapy regimen and Bone marrow.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
